Abdol Mojab
Hematology & Oncology · Modesto, CANPI 1194744136
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,130 of the $9,338 with a category attached, or 76.4%. 50 manufacturers reported payments, led by Novartis at 24.1% of the total. Reporting peaked in 2021 at $3,020 and has fallen 96.3% since, to $111 in 2024.
Across 420 payments — averaging $22.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- Amgen$680
- Pfizer$583
- Merck$501
- Johnson & Johnson$474
- AstraZeneca$448
- plus $4K from 44 others
What the payments were for
- Food & beverage$7,13076%
- Education$5105%
- Other$1,69818%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$9,338 in reported general payments places this provider in the 65th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in Modesto
- Dennis SlamonLos Angeles$3.1M
- Sandra HorningStanford$2.5M
- Mohammadbagher ZiariCorona$2.5M
- George YaghmourLos Angeles$1.9M
- Robert VescioWest Hollywood$1.1M
- Kevin KellyLos Angeles$894K
- Johnny ChangEncino$884K
- Nitin RohatgiSacramento$814K
- Omid HamidSanta Monica$809K
- Catherine CoombsOrange$786K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.